TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
TandemAI delivers a computational platform to accelerate the design and optimization of drug candidates.
TandemAI was founded in 2021 by Jeff He and Wei Tang. The company is headquartered in Suzhou, and Shangai, China.
TandemAI integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
TandemAI has built its networked platform from the ground up in China to increase the speed of drug discovery and deliver cost-effective opportunities to its partners and to the global scientific community.
TandemAI has raised $25M in Seed & Pre-series A round on Dec 22, 2021. The round was led by OrbiMed and Chengwei Capital.